Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,709 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,356
Recruiting: 3,959
Ph III recruiting: 534
Growth YoY: +9.8%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,403)

clinicaltrialsPublishedShowing 51–100 of 25,709 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06997497	A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)	recruiting	Phase 3	477	Merck Sharp & Dohme LLCINDUSTRY	29	Sep 28, 2026	clinicaltrials
NCT07005297	Clinical Genetics Branch Eligibility Screening Survey	not yet recruiting	—	1,000	National Cancer Institute (NCI)NIH	1	Sep 28, 2026	clinicaltrials